SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
15-Oct-24 5:03 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 15-Oct-24 | Option Exercise | 5,000 | $45.28 | $226,384.00 | 2% 220.71K to 225.71K | |
15-Oct-24 5:03 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 15-Oct-24 | Planned Option Sale | 5,000 | $69.51 | $347,534.00 | (2%) 225.71K to 220.71K | |
16-Sep-24 8:17 PM View: | Markowitz Wayne GM & SVP, Surgical | Edwards Lifesciences Corp. (EW) | 14-Sep-24 | Payment of Exercise | 648 | $68.52 | $44,401.00 | (6%) 10.68K to 10.03K | |
16-Sep-24 5:25 PM View: | Dahl Andrew M. SVP, Corporate Controller | Edwards Lifesciences Corp. (EW) | 13-Sep-24 | Grant | 2,920 | -- | -- | 165% 1.77K to 4.69K | |
11-Sep-24 6:06 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 11-Sep-24 | Planned Option Sale | 5,000 | $66.77 | $333,826.00 | (2%) 225.71K to 220.71K | |
11-Sep-24 6:06 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 11-Sep-24 | Option Exercise | 5,000 | $45.28 | $226,384.00 | 2% 220.71K to 225.71K | |
03-Sep-24 7:10 PM View: | Szyman Catherine M CVP, Critical Care | Edwards Lifesciences Corp. (EW) | 03-Sep-24 | Payment of Exercise | 5,530 | $69.96 | $386,879.00 | (6%) 86.82K to 81.29K | |
03-Sep-24 7:10 PM View: | Szyman Catherine M CVP, Critical Care | Edwards Lifesciences Corp. (EW) | 03-Sep-24 | Grant | 10,910 | -- | -- | 14% 75.91K to 86.82K | |
20-Aug-24 7:42 PM View: | Chopra Daveen CVP, TMTT | Edwards Lifesciences Corp. (EW) | 20-Aug-24 | Sale | 1,250 | $69.95 | $87,437.60 | (4%) 30.58K to 29.33K | |
14-Aug-24 5:58 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 14-Aug-24 | Option Exercise | 5,000 | $45.28 | $226,384.00 | 2% 220.71K to 225.71K | |
14-Aug-24 5:58 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 14-Aug-24 | Planned Option Sale | 5,000 | $66.08 | $330,420.00 | (2%) 225.71K to 220.71K | |
11-Jul-24 5:38 PM View: | Lippis Daniel J. CVP, JAPAC | Edwards Lifesciences Corp. (EW) | 11-Jul-24 | Planned Option Sale | 500 | $94.18 | $47,090.00 | (2%) 23.69K to 23.19K | |
11-Jul-24 5:38 PM View: | Lippis Daniel J. CVP, JAPAC | Edwards Lifesciences Corp. (EW) | 11-Jul-24 | Option Exercise | 500 | $45.28 | $22,638.30 | 2% 23.19K to 23.69K | |
10-Jul-24 5:36 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 10-Jul-24 | Option Exercise | 5,000 | $45.28 | $226,384.00 | 2% 220.7K to 225.7K | |
10-Jul-24 5:36 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 10-Jul-24 | Planned Option Sale | 5,000 | $93.29 | $466,474.00 | (2%) 225.7K to 220.7K | |
10-Jul-24 5:36 PM View: | Feinberg David T Director | Edwards Lifesciences Corp. (EW) | 10-Jul-24 | Grant | 2,308 | -- | -- | 100% 0 to 2.31K | |
08-Jul-24 6:26 PM View: | Lippis Daniel J. CVP, JAPAC | Edwards Lifesciences Corp. (EW) | 07-Jul-24 | Payment of Exercise | 410 | $92.32 | $37,851.20 | (2%) 23.6K to 23.19K | |
08-Jul-24 6:26 PM View: | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Edwards Lifesciences Corp. (EW) | 07-Jul-24 | Payment of Exercise | 82 | $92.32 | $7,570.24 | (< 1%) 184.77K to 184.69K | |
08-Jul-24 6:26 PM View: | Szyman Catherine M CVP, Critical Care | Edwards Lifesciences Corp. (EW) | 07-Jul-24 | Payment of Exercise | 258 | $92.32 | $23,818.60 | (< 1%) 76.17K to 75.91K | |
20-Jun-24 5:43 PM View: | Ullem Scott B. CVP, Chief Financial Officer | Edwards Lifesciences Corp. (EW) | 20-Jun-24 | Option Exercise | 5,625 | $45.28 | $254,681.00 | 2% 296.88K to 302.5K | |
20-Jun-24 5:44 PM View: | Lippis Daniel J. CVP, JAPAC | Edwards Lifesciences Corp. (EW) | 20-Jun-24 | Planned Option Sale | 535 | $90.00 | $48,150.00 | (2%) 24.05K to 23.51K | |
20-Jun-24 5:44 PM View: | Lippis Daniel J. CVP, JAPAC | Edwards Lifesciences Corp. (EW) | 20-Jun-24 | Option Exercise | 535 | $45.28 | $24,223.00 | 2% 23.51K to 24.05K | |
20-Jun-24 5:43 PM View: | Ullem Scott B. CVP, Chief Financial Officer | Edwards Lifesciences Corp. (EW) | 20-Jun-24 | Planned Option Sale | 5,625 | $87.51 | $492,258.00 | (2%) 302.5K to 296.88K | |
12-Jun-24 5:19 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 12-Jun-24 | Option Exercise | 5,000 | $45.28 | $226,384.00 | 2% 220.7K to 225.7K | |
12-Jun-24 5:19 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 12-Jun-24 | Planned Option Sale | 5,000 | $87.54 | $437,696.00 | (2%) 225.7K to 220.7K | |
30-May-24 5:10 PM View: | Zovighian Bernard J CEO Director | Edwards Lifesciences Corp. (EW) | 30-May-24 | Sale (Planned) | 8,617 | $87.68 | $755,539.00 | (11%) 80.1K to 71.49K | |
21-May-24 5:09 PM View: | Ullem Scott B. CVP, Chief Financial Officer | Edwards Lifesciences Corp. (EW) | 21-May-24 | Planned Option Sale | 5,625 | $90.45 | $508,803.00 | (2%) 302.5K to 296.88K | |
21-May-24 5:09 PM View: | Ullem Scott B. CVP, Chief Financial Officer | Edwards Lifesciences Corp. (EW) | 21-May-24 | Option Exercise | 5,625 | $45.28 | $254,681.00 | 2% 296.88K to 302.5K | |
13-May-24 5:47 PM View: | Wood Larry L Global President TAVR & Surg | Edwards Lifesciences Corp. (EW) | 11-May-24 | Payment of Exercise | 985 | $86.72 | $85,419.20 | (< 1%) 225.01K to 224.02K | |
13-May-24 5:45 PM View: | Ullem Scott B. CVP, Chief Financial Officer | Edwards Lifesciences Corp. (EW) | 11-May-24 | Payment of Exercise | 1,198 | $86.72 | $103,891.00 | (< 1%) 298.08K to 296.88K | |
13-May-24 5:45 PM View: | Chopra Daveen CVP, TMTT | Edwards Lifesciences Corp. (EW) | 11-May-24 | Payment of Exercise | 821 | $86.72 | $71,197.10 | (3%) 31.4K to 30.58K | |
13-May-24 5:45 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 11-May-24 | Payment of Exercise | 814 | $86.72 | $70,590.10 | (< 1%) 221.52K to 220.7K | |
13-May-24 5:46 PM View: | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Edwards Lifesciences Corp. (EW) | 11-May-24 | Payment of Exercise | 21 | $86.72 | $1,821.12 | (< 1%) 184.79K to 184.77K | |
13-May-24 5:47 PM View: | Sellers Robert W.A. SVP, Corporate Controller | Edwards Lifesciences Corp. (EW) | 11-May-24 | Payment of Exercise | 229 | $86.72 | $19,858.90 | (< 1%) 37.72K to 37.49K | |
13-May-24 5:45 PM View: | Zovighian Bernard J CEO Director | Edwards Lifesciences Corp. (EW) | 11-May-24 | Payment of Exercise | 2,854 | $86.72 | $247,499.00 | (3%) 82.96K to 80.1K | |
13-May-24 5:46 PM View: | Lippis Daniel J. CVP, JAPAC | Edwards Lifesciences Corp. (EW) | 11-May-24 | Payment of Exercise | 377 | $86.72 | $32,693.40 | (2%) 23.89K to 23.51K | |
13-May-24 5:47 PM View: | Szyman Catherine M CVP, Critical Care | Edwards Lifesciences Corp. (EW) | 11-May-24 | Payment of Exercise | 827 | $86.72 | $71,717.40 | (1%) 76.99K to 76.17K | |
13-May-24 5:45 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 10-May-24 | Option Exercise | 5,000 | $45.28 | $226,384.00 | 2% 221.52K to 226.52K | |
13-May-24 5:45 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 10-May-24 | Planned Option Sale | 5,000 | $87.81 | $439,038.00 | (2%) 226.52K to 221.52K | |
09-May-24 7:41 PM View: | Gallahue Kieran Director | Edwards Lifesciences Corp. (EW) | 08-May-24 | Grant | 4,054 | -- | -- | 6% 70.92K to 74.97K | |
09-May-24 7:42 PM View: | Laviolette Paul A Director | Edwards Lifesciences Corp. (EW) | 08-May-24 | Grant | 3,055 | -- | -- | 40% 7.72K to 10.77K | |
09-May-24 7:41 PM View: | Stone Heisz Leslie Director | Edwards Lifesciences Corp. (EW) | 08-May-24 | Grant | 3,055 | -- | -- | 11% 26.98K to 30.04K | |
09-May-24 7:42 PM View: | Valeriani Nicholas J Director | Edwards Lifesciences Corp. (EW) | 08-May-24 | Grant | 4,818 | -- | -- | 7% 68.91K to 73.73K | |
09-May-24 7:42 PM View: | Sequeira Ramona Director | Edwards Lifesciences Corp. (EW) | 08-May-24 | Grant | 3,055 | -- | -- | 28% 11.02K to 14.08K | |
09-May-24 7:43 PM View: | Loranger Steven R Director | Edwards Lifesciences Corp. (EW) | 08-May-24 | Grant | 4,054 | -- | -- | 6% 71.32K to 75.37K | |
09-May-24 7:41 PM View: | Davis Leslie C. Director | Edwards Lifesciences Corp. (EW) | 08-May-24 | Grant | 3,055 | -- | -- | 100% 0 to 3.06K | |
09-May-24 7:39 PM View: | Wood Larry L Global President TAVR & Surg | Edwards Lifesciences Corp. (EW) | 07-May-24 | Grant | 8,725 | -- | -- | 4% 216.98K to 225.7K | |
09-May-24 7:39 PM View: | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Edwards Lifesciences Corp. (EW) | 07-May-24 | Payment of Exercise | 46 | $85.09 | $3,914.14 | (< 1%) 184.84K to 184.79K | |
09-May-24 7:38 PM View: | Ullem Scott B. CVP, Chief Financial Officer | Edwards Lifesciences Corp. (EW) | 07-May-24 | Grant | 11,075 | -- | -- | 4% 287.79K to 298.87K | |
09-May-24 7:40 PM View: | Lippis Daniel J. CVP, JAPAC | Edwards Lifesciences Corp. (EW) | 07-May-24 | Grant | 7,560 | -- | -- | 45% 16.92K to 24.48K |